GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
RDLCX
Price
$9.21
Change
-$0.25 (-2.64%)
Updated
Feb 21 closing price
Net Assets
311.71M
Ad is loading...

GFACX vs RDLCX

Header iconGFACX vs RDLCX Comparison
Open Charts GFACX vs RDLCXBanner chart's image
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
Columbia Disciplined Growth C
Price$9.21
Change-$0.25 (-2.64%)
VolumeN/A
Net Assets311.71M
GFACX vs RDLCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. RDLCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and RDLCX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. RDLCX (312M). GFACX (0.00) and RDLCX (0.00) have matching dividends . GFACX was incepted earlier than RDLCX: GFACX (24 years) vs RDLCX (18 years). RDLCX is a more actively managed with annual turnover of: 71.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than RDLCX: GFACX (250) vs RDLCX (2000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. RDLCX (4.42). GFACX return over 5 years is better than : 32.83 vs. RDLCX (2.22).
GFACXRDLCXGFACX / RDLCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years18 years-
Gain YTD2.9800.000-
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets304B312M97,436%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.154.42230%
Returns for 3 years17.698.35212%
Returns for 5 years32.832.221,479%
Returns for 10 years55.630.995,637%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding